logo

Inozyme Pharma, Inc. (INZY)



Trade INZY now with
  Date
  Headline
5/10/2022 4:59:05 PM Wedbush Is Increasing Inozyme Pharma, Inc. (INZY) FY22 Estimate To -1.85 From -2.55
5/10/2022 4:58:50 PM Wedbush Is Raising Inozyme Pharma, Inc. (INZY) Q4 22 Estimate To -0.37 From -0.67
5/10/2022 4:58:34 PM Wedbush Is Increasing Inozyme Pharma, Inc. (INZY) Q3 22 Estimate To -0.48 From -0.59
5/10/2022 4:58:16 PM Wedbush Is Increasing Inozyme Pharma, Inc. (INZY) Q2 22 Estimate To -0.43 From -0.53
5/10/2022 4:57:48 PM Wedbush Reiterates Inozyme Pharma, Inc. (INZY) At Outperform With $23 Down From $25 Price Target
3/16/2022 10:35:55 AM Wedbush Is Lowering Inozyme Pharma, Inc. (INZY) FY 22 Estimate To -2.55 From -2.40
3/16/2022 10:35:39 AM Wedbush Is Lowering Inozyme Pharma, Inc. (INZY) Q4 22 Estimate To -0.67 From -0.65
3/16/2022 10:35:21 AM Wedbush Is Increasing Inozyme Pharma, Inc. (INZY) Q3 22 Estimate To -0.59 From -0.66
3/16/2022 10:35:06 AM Wedbush Is Increasing Inozyme Pharma, Inc. (INZY) Q2 22 Estimate To -0.53 From -0.58
3/16/2022 10:34:51 AM Wedbush Is Cutting Inozyme Pharma, Inc. (INZY) Q1 22 Estimate To -0.87 From -0.51
3/16/2022 10:34:19 AM Wedbush Reiterates Inozyme Pharma, Inc. (INZY) At Outperform With $25 Down From $35 Price Target
8/11/2021 6:19:24 AM Inozyme Pharma Q2 Net Loss $12.5 Mln Or $0.53/Shr Vs Loss $9.5 Mln Or $7.57/Shr Last Year
5/12/2021 6:10:39 AM Inozyme Pharma Q1 Net Loss $11.1 Mln Or $0.47/Shr Vs Loss $7.7 Mln Or $6.42/Shr Last Year